• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】Holmium-166-DOTMP , 166Ho-DOTMP

【化学名称】1,1',1'',1'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis(methylphosphonic acid) 166holmium complex

【CA登记号】

【 分 子 式 】C12H32HoN4O12P4

【 分 子 量 】714.30364

【开发单位】International Isotopes (Supplier), Aventis Pharma (Originator), NeoRx (Licensee)

【药理作用】Multiple Myeloma Therapy, Oncolytic Drugs, Radiation Therapy

合成路线1

The reaction of 1,4,7,10-tetraazacyclododecane (I) with formaldehyde and phosphoric acid in refluxing aqueous HCl gives the tetraphosphonic acid (II), which is then treated with aqueous 166HoCl3 to obtain the target chelate.

1 Simon, J.; Garlich, J.R.; Wilson, D.A.; McMillan, K. (Marion Merrell Dow, Inc.); Bone marrow suppressing agents. EP 0374501; JP 1990237936; US 4882142 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14855 1,4,7,10-tetraazacyclododecane; Cyclen 294-90-6 C8H20N4 详情 详情
(II) 49689 [4,7,10-tris(phosphonomethyl)-1,4,7,10-tetraazacyclododecan-1-yl]methylphosphonic acid C12H32N4O12P4 详情 详情
Extended Information